Since Aardvark Therapeutics was founded in 2017, it has participated in 5 rounds of funding. In total Aardvark Therapeutics has raised $223.2M. Aardvark Therapeutics' last funding round was on Feb 2025 for a total of $94.2M.
Aardvark Therapeutics has 16 investors, including Decheng Capital, Cormorant Asset Management and SymBiosis. The latest investment occurred in Feb 2025.
